min Sekce: Focused on

Fully Reimbursed Medicinal Products in the Czech Health Insurance System

Fully reimbursed medicinal products play a key role in ensuring access to healthcare for patients in the Czech Republic. Their regulation is based on the Public Health Insurance Act, which aims to...
Pharmeca a.s. 04/02/2025
min Sekce: Daily overview

Selection from Decision-Making Practice - 5

The Institute may not conduct its own pharmacoeconomic analyses
Pharmeca a.s. 04/02/2025
min Sekce: Daily overview

Selection from Decision-Making Practice - 4

Ensuring the Right to Full Reimbursement for Medicinal Products Listed in Annex No. 2
Pharmeca a.s. 03/26/2025
min Sekce: Focused on

Roles of Key Stakeholders in the Drug Reimbursement Process in the Czech Republic

The process of determining the reimbursement of medicinal products in the Czech Republic is complex and involves several key stakeholders who collectively influence the final decision. In our...
Pharmeca a.s. 03/21/2025
min Sekce: Daily overview

Selection from Decision-Making Practice - 3

Health Insurance Companies' Statement on the Unacceptability of Budget Impact.
Pharmeca a.s. 03/19/2025
min Sekce: Daily overview

Selection from Decision-Making Practice - 2

The State Institute for Drug Control questioned the cost-effectiveness presented in the administrative proceedings.
Pharmeca a.s. 03/12/2025
min Sekce: Daily overview

Selection from Decision-Making Practice

Multiple reimbursement levels for JAKi in reimbursement review.
Pharmeca a.s. 03/05/2025
min Sekce: Daily overview

EMA Launches New Platform to Monitor Medicine Shortages

The European Medicines Agency (EMA) has announced the launch of a new platform designed to routinely monitor shortages of centrally authorized medicines.
Pharmeca a.s. 01/31/2025